ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

156 Afleveringen

1. ACCEL Lite: Optimizing the Care of ASCVD Patients with T2DM

   Gepubliceerd: 25-4-2023
2. ACCEL Lite: Revascularization of Stable Ischemic Heart Disease in the Era of COURAGE, ISCHEMIA, and ORBITA

   Gepubliceerd: 18-4-2023
3. ACCEL Lite: Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI?

   Gepubliceerd: 13-4-2023
4. ACCEL Lite: Understanding the Basics of HF-rEF and Work Up

   Gepubliceerd: 11-4-2023
5. ACCEL Lite: ISCHEMIA-EXTENDed – Follow-Up Interim Report

   Gepubliceerd: 4-4-2023
6. ACCEL Lite: ACC.23 Late-Breaker: Bempedoic Acid and Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk

   Gepubliceerd: 28-3-2023
7. ACCEL Lite: When Lifestyle Isn't Enough: Surgical vs. Pharmacological Approaches for Obesity

   Gepubliceerd: 21-3-2023
8. ACCEL Lite: ACC.23 Late-Breaker: Vigorous Exercise in Individuals with Hypertrophic Cardiomyopathy: Primary Results of the LIVE-HCM Study

   Gepubliceerd: 14-3-2023
9. ACCEL Lite: Statins To Prevent The Cardiotoxicity From Anthracyclines: The STOP-CA Trial

   Gepubliceerd: 7-3-2023
10. ACCEL Lite: From JACC: CACS Improves Risk Prediction in Patients with Suspected Obstructive CAD

    Gepubliceerd: 28-2-2023
11. ACCEL Lite: PRECISE – Comparison of a Precision Care Strategy with Usual Testing to Guide Management of Stable Patients With Suspected CAD

    Gepubliceerd: 21-2-2023
12. ACCEL Lite: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in HFrEF

    Gepubliceerd: 14-2-2023
13. PROMINENT – A Randomized Trial of Pemafibrate for Triglyceride Reduction in the Prevention of CVD

    Gepubliceerd: 7-2-2023
14. ACCEL Lite: AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression

    Gepubliceerd: 31-1-2023
15. AHA Late-Breaker: OCEAN(a)-DOSE – Reduction of Lipoprotein(a) With Small Interfering RNA

    Gepubliceerd: 24-1-2023
16. AHA Late-Breaker: EMPA-KIDNEY – Empagliflozin and CV Outcomes in Patients with CKD

    Gepubliceerd: 17-1-2023
17. AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results

    Gepubliceerd: 10-1-2023
18. ACCEL Lite: Top Takeaways from 2022: General Cardiology with Glenn Hirsch MD

    Gepubliceerd: 22-12-2022
19. ACCEL Lite: Top Takeaways from 2022: Preventive Cardiology with Martha Gulati MD

    Gepubliceerd: 20-12-2022
20. ACCEL Lite: Top Takeaways from 2022: Interventional Cardiology with Dipti Itchhaporia MD

    Gepubliceerd: 13-12-2022